116 related articles for article (PubMed ID: 18508438)
21. Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy.
Okamoto H; Fujishima F; Kamei T; Nakamura Y; Ozawa Y; Miyata G; Nakano T; Katsura K; Abe S; Taniyama Y; Sakurai T; Teshima J; Hikage M; Sasano H; Ohuchi N
BMC Cancer; 2015 Mar; 15():208. PubMed ID: 25880782
[TBL] [Abstract][Full Text] [Related]
22. Association of p53 and MDM2 polymorphisms with risk of human papillomavirus (HPV)-related esophageal squamous cell carcinoma (ESCC).
Yang J; Liu B; Li W; Xiong H; Qiu H; Fu Q; Chen B; Hu G; Yuan X
Cancer Epidemiol; 2013 Oct; 37(5):629-33. PubMed ID: 23837945
[TBL] [Abstract][Full Text] [Related]
23. p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.
Makino T; Yamasaki M; Miyata H; Yoshioka S; Takiguchi S; Fujiwara Y; Nakajima K; Nishida T; Mori M; Doki Y
Ann Surg Oncol; 2010 Mar; 17(3):804-11. PubMed ID: 19885698
[TBL] [Abstract][Full Text] [Related]
24. Association of p53 protein expression with responses and survival of patients with locally advanced esophageal carcinoma treated with chemoradiotherapy.
Muro K; Ohtsu A; Boku N; Chin K; Oda Y; Fujii T; Hosokawa K; Yoshida S; Hasebe T
Jpn J Clin Oncol; 1996 Apr; 26(2):65-9. PubMed ID: 8609696
[TBL] [Abstract][Full Text] [Related]
25. Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53.
He T; Guo J; Song H; Zhu H; Di X; Min H; Wang Y; Chen G; Dai W; Ma J; Sun X; Ma J
Pathol Oncol Res; 2018 Jan; 24(1):75-81. PubMed ID: 28341911
[TBL] [Abstract][Full Text] [Related]
26. Expression of p21(Waf1/Cip1) predicts response and survival of esophageal cancer patients treated by chemoradiotherapy.
Nakamura T; Hayashi K; Ota M; Ide H; Takasaki K; Mitsuhashi M
Dis Esophagus; 2004; 17(4):315-21. PubMed ID: 15569370
[TBL] [Abstract][Full Text] [Related]
27. INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy--Introgen, RPR/INGN 201.
BioDrugs; 2003; 17(3):216-22. PubMed ID: 12749760
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.
Miyake H; Yamanaka K; Muramaki M; Hara I; Gleave ME
Neoplasia; 2005 Feb; 7(2):171-9. PubMed ID: 15802022
[TBL] [Abstract][Full Text] [Related]
29. Adenovirus-mediated p14ARF gene transfer cooperates with Ad5CMV-p53 to induce apoptosis in human cancer cells.
Tango Y; Fujiwara T; Itoshima T; Takata Y; Katsuda K; Uno F; Ohtani S; Tani T; Roth JA; Tanaka N
Hum Gene Ther; 2002 Jul; 13(11):1373-82. PubMed ID: 12162819
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus infection increases the chemoradiation response of esophageal squamous cell carcinoma based on P53 mutation.
Zhang D; Zhang W; Liu W; Mao Y; Fu Z; Liu J; Huang W; Zhang Z; An D; Li B
Radiother Oncol; 2017 Jul; 124(1):155-160. PubMed ID: 28647401
[TBL] [Abstract][Full Text] [Related]
31. Co-transduction of ribosomal protein L23 enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in human gastric cancer.
Zhang YF; Zhang BC; Zhang AR; Wu TT; Liu J; Yu LF; Wang WX; Gao JF; Fang DC; Rao ZG
Oncol Rep; 2013 Oct; 30(4):1989-95. PubMed ID: 23933826
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma.
Weinrib L; Li JH; Donovan J; Huang D; Liu FF
Cancer Gene Ther; 2001 May; 8(5):352-60. PubMed ID: 11477455
[TBL] [Abstract][Full Text] [Related]
33. In vivo gene therapy with p53 or p21 adenovirus for prostate cancer.
Eastham JA; Hall SJ; Sehgal I; Wang J; Timme TL; Yang G; Connell-Crowley L; Elledge SJ; Zhang WW; Harper JW
Cancer Res; 1995 Nov; 55(22):5151-5. PubMed ID: 7585563
[TBL] [Abstract][Full Text] [Related]
34. Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status.
Saadatmandi N; Tyler T; Huang Y; Haghighi A; Frost G; Borgstrom P; Gjerset RA
Cancer Gene Ther; 2002 Oct; 9(10):830-9. PubMed ID: 12224024
[TBL] [Abstract][Full Text] [Related]
35. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
[TBL] [Abstract][Full Text] [Related]
36. p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis.
Ito S; Ohga T; Saeki H; Nakamura T; Watanabe M; Tanaka S; Kakeji Y; Maehara Y
Int J Cancer; 2005 Jan; 113(1):22-8. PubMed ID: 15386362
[TBL] [Abstract][Full Text] [Related]
37. Id-1 promotes proliferation of p53-deficient esophageal cancer cells.
Hui CM; Cheung PY; Ling MT; Tsao SW; Wang X; Wong YC; Cheung AL
Int J Cancer; 2006 Aug; 119(3):508-14. PubMed ID: 16506209
[TBL] [Abstract][Full Text] [Related]
38. Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis.
Güner D; Sturm I; Hemmati P; Hermann S; Hauptmann S; Wurm R; Budach V; Dörken B; Lorenz M; Daniel PT
Int J Cancer; 2003 Feb; 103(4):445-54. PubMed ID: 12478659
[TBL] [Abstract][Full Text] [Related]
39. In vivo recombinant adenovirus-mediated p53 gene therapy in a syngeneic rat model for colorectal cancer.
Baek JH; Agarwal ML; Tubbs RR; Vladisavljevic A; Tomita H; Bukowski RM; Milsom JW; Kim JM; Kwak JY
J Korean Med Sci; 2004 Dec; 19(6):834-41. PubMed ID: 15608394
[TBL] [Abstract][Full Text] [Related]
40. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma.
Shibagaki I; Tanaka H; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
Clin Cancer Res; 1995 Jul; 1(7):769-73. PubMed ID: 9816044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]